Absence of mutations in the coding sequence of the potential tumor suppressor 3pK in metastatic melanoma

Por Houben Roland, Becker Jürgen C, Rapp Ulf R
Publicado em 2005-12-01

Absence of mutations in the coding sequence of the potential tumor suppressor 3pK in metastatic melanoma

Por Houben, Roland, Becker, Jürgen C, Rapp, Ulf R
Publicado em 2005

Mycosis fungoides bullosa: a case report and review of the literature

Por Kneitz, Hermann, Bröcker, Eva-B, Becker, Jürgen C
Publicado em 2010

Sclerosing ‘Mucinous’ Blue Nevus: A Clinical Simulator of Dermatofibroma

Por Vetter-Kauczok, Claudia-S., Becker, Jürgen-C., Bröcker, Eva-B.
Publicado em 2008

The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report

Por Becker, Jürgen C, Houben, Roland, Vetter, Claudia S, Bröcker, Eva B
Publicado em 2006

T-cell clonotypes in cancer

Por thor Straten, Per, Schrama, David, Andersen, Mads Hald, Becker, Jürgen C
Publicado em 2004

Kaposiform hemangioendothelioma with distant lymphangiomatosis without an association to Kasabach-Merritt-Syndrome in a female adult!

Por Vetter-Kauczok, Claudia S, Ströbel, Philipp, Bröcker, Eva B, Becker, Jürgen C
Publicado em 2008

Lack of Wnt5A Expression in Merkel Cell Carcinoma

Por Weeraratna, Ashani T., Houben, Roland, O’Connell, Michael P., Becker, Jürgen C.
Publicado no Arch Dermatol (2010)

HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer

Por Andersen, Mads Hald, Soerensen, Rikke B, Becker, Jürgen C, thor Straten, Per
Publicado em 2006

Cellular and cytokine-dependent immunosuppressive mechanisms of grm1-transgenic murine melanoma

Por Alb, Miriam, Sie, Christopher, Adam, Christian, Chen, Suzie, Becker, Jürgen C., Schrama, David
Publicado em 2012

HLA-B8 association with late-stage melanoma – an immunological lesson?

Por Fensterle, Joachim, Trefzer, Uwe, Berger, Thomas, Andersen, Mads Hald, Ugurel, Selma, Becker, Jürgen C
Publicado em 2006

Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma

Por Ritter, Cathrin, Fan, Kaiji, Paulson, Kelly G., Nghiem, Paul, Schrama, David, Becker, Jürgen C.
Publicado no Sci Rep (2016)

Activation of preexisting T cell clones by targeted interleukin 2 therapy

Por thor Straten, Per, Guldberg, Per, Seremet, Tina, Reisfeld, Ralph A., Zeuthen, Jesper, Becker, Jürgen C.
Publicado em 1998

Quantitation of Human Seroresponsiveness to Merkel Cell Polyomavirus

Por Pastrana, Diana V., Tolstov, Yanis L., Becker, Jürgen C., Moore, Patrick S., Chang, Yuan, Buck, Christopher B.
Publicado em 2009

Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes

Por Køllgaard, Tania, Ugurel-Becker, Selma, Idorn, Manja, Andersen, Mads Hald, Becker, Jürgen C., Straten, Per thor
Publicado no PLoS One (2015)

Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis

Por Houben Roland, Becker Jürgen C, Kappel Andreas, Terheyden Patrick, Bröcker Eva-B, Goetz Rudolf, Rapp Ulf R
Publicado em 2004-03-01

Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis

Por Houben, Roland, Becker, Jürgen C, Kappel, Andreas, Terheyden, Patrick, Bröcker, Eva-B, Goetz, Rudolf, Rapp, Ulf R
Publicado em 2004

B-Raf specific antibody responses in melanoma patients

Por Fensterle, Joachim, Becker, Jürgen C, Potapenko, Tamara, Heimbach, Veronika, Vetter, Claudia S, Bröcker, Eva B, Rapp, Ulf R
Publicado em 2004

BRAF(V600E )mutations in malignant melanoma are associated with increased expressions of BAALC

Por Schrama, David, Keller, Gunhild, Houben, Roland, Ziegler, Christian G, Vetter-Kauczok, Claudia S, Ugurel, Selma, Becker, Jürgen C
Publicado em 2008

Cancer treatment: the combination of vaccination with other therapies

Por Andersen, Mads Hald, Sørensen, Rikke Bæk, Schrama, David, Svane, Inge Marie, Becker, Jürgen C., thor Straten, Per
Publicado em 2008